Avoro Capital Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Avoro Capital Advisors’s Portfolio CRSP Stock Details CRSP Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell
2024 Q1	$28.6M	Buy
2018 Q4	–	Sell
2018 Q3	$6.54M	Buy